Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
TrivarX Limited ( (AU:TRI) ) has provided an update.
TrivarX Limited has issued 1,627,653 ordinary fully paid shares at $0.016 per share to satisfy consulting fees, as per Section 708A of the Corporations Act 2001. This issuance was made without disclosure to investors under the Act, and the company has affirmed its compliance with relevant legal provisions, ensuring transparency and maintaining investor confidence.
More about TrivarX Limited
TrivarX Limited is a mental health technology company that focuses on using objective measures for the early detection and screening of mental health conditions. The company was founded in Australia, with offices in Perth and Minneapolis, and is listed on the Australian Securities Exchange and OTCQB Venture Market.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.6M
Find detailed analytics on TRI stock on TipRanks’ Stock Analysis page.
